Mitchell Levine
Overview
Explore the profile of Mitchell Levine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
1515
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng R, Tao L, Sun Y, Shang H, Levine M
J Evid Based Med
. 2025 Feb;
18(1):e70006.
PMID: 40016152
Objective: To assess the quality of harm reporting in randomized controlled trials (RCTs) published in high-impact general medical journals. Study Design And Setting: Publications of RCTs involving drugs compared with...
2.
Fashami F, Tarride J, Sadeghirad B, Hariri K, Peyrovinasab A, Levine M
Pharmacoecon Open
. 2024 Sep;
8(6):963-965.
PMID: 39287921
No abstract available.
3.
Fashami F, Tarride J, Sadeghirad B, Hariri K, Peyrovinasab A, Levine M
Pharmacoecon Open
. 2024 Aug;
8(6):823-836.
PMID: 39103675
Introduction: Identifying key differences between manufacturers' submitted analysis and economic reanalysis by the Canadian Agency for Drugs and Technologies in Health (CADTH) is an important step toward understanding reimbursement recommendations....
4.
Jeddi H, Busse J, Sadeghirad B, Levine M, Zoratti M, Wang L, et al.
BMJ Open
. 2024 Jan;
14(1):e068182.
PMID: 38171632
Objective: The objective of this study is to evaluate the comparative benefits and harms of opioids and cannabis for medical use for chronic non-cancer pain. Design: Systematic review and network...
5.
Zhang M, Yang Y, Bao Y, Kimber M, Levine M, Xie F
Value Health
. 2023 Dec;
27(3):330-339.
PMID: 38135215
Objectives: This study aimed to develop the scoring functions for the recently developed value assessment framework (VAF) for China, which comprises 12 attributes. Methods: We implemented a factorial survey among...
6.
Fashami F, Levine M, Xie F, Blackhouse G, Tarride J
Curr Oncol
. 2023 May;
30(5):4688-4699.
PMID: 37232812
Pancreatic cancer has an annual incidence of 2/10,000 in Canada, with a one-year mortality rate greater than 80%. In the absence of a cost-effectiveness analysis in Canada, this study's objective...
7.
Levine M
Ann Intern Med
. 2023 Mar;
176(3):JC31.
PMID: 36877971
Lee DS, Straus SE, Farkouh ME, et al. N Engl J Med. 2023;388:22-32. 36342109.
8.
Levine M
Ann Intern Med
. 2023 Mar;
176(3):JC31.
PMID: 36877970
Mebazaa A, Davison B, Chioncel O, et al. Lancet. 2022;400:1938-52. 36356631.
9.
Zhang M, Bao Y, Yang Y, Kimber M, Levine M, Xie F
Pharmacoeconomics
. 2023 Feb;
41(4):439-455.
PMID: 36729295
Background: Value assessment frameworks (VAFs) are promising tools for measuring the value of health technologies and informing coverage policymaking; however, most published VAFs were developed for high-income countries. This study...
10.
Devasenapathy N, Chu A, Wong M, Srivastava A, Ceccacci R, Lin C, et al.
Lancet Child Adolesc Health
. 2022 Nov;
7(1):13-25.
PMID: 36370744
Background: Atopic dermatitis is a prevalent condition in children and can be effectively managed with medications such as topical calcineurin inhibitors (pimecrolimus or tacrolimus). A key unresolved safety concern is...